Detalles de la búsqueda
1.
Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs).
Front Pharmacol
; 14: 1229960, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492082
2.
Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines.
Br J Pharmacol
; 154(7): 1427-38, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18493243
3.
A new method to calculate the beat-to-beat instability of QT duration in drug-induced long QT in anesthetized dogs.
J Pharmacol Toxicol Methods
; 52(1): 168-77, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15935709
4.
Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.
Br J Pharmacol
; 172(17): 4364-79, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26076100
5.
Selective vasoconstriction by alniditan in the carotid vascular bed of anaesthetized dogs.
Eur J Pharmacol
; 299(1-3): 127-37, 1996 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-8901015
6.
QT and JT dispersion in the drug-induced long QT syndrome in anaesthetized rabbits is accurately detected by a three-lead surface ECG measurement.
J Pharmacol Toxicol Methods
; 49(2): 71-9, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-14990331
7.
Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
Circ Res
; 69(2): 313-24, 1991 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-1830517
Resultados
1 -
7
de 7
1
Próxima >
>>